References
- 1World Health Organization.
WHO Global Hepatitis Report . World Health Organization; 2017. - 2Moraga, P. GBD 2016 Causes of Death Collaborators Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100): 1151–1210.
- 3World Health Organization. Advocacy brief. Combating Hepatitis B and C to reach elimination by 2030. World Health Organization; 2016.
- 4World Health Organization. Guidelines on hepatitis B and C testing. New evidence-based global guidelines on who to test and how to test for chronic hepatitis B and C, and strategies for implementation. World Health Organization; 2017.
- 5Vedio AB, Ellam H, Rayner F. Hepatitis B: Report of prevalence and access to healthcare among Chinese residents in Sheffield UK. J Infect Public Health. 2013; 6(6): 448–55. DOI: 10.1016/j.jiph.2013.05.004
- 6Veldhuijzen IK, Wolter R, Rijckborst V. Identification and treatment of chronic hepatitis B in Chinese migrants: Results of a project offering on-site testing in Rotterdam, The Netherlands. J Hepatol. 2012; 57(6): 1171–6. DOI: 10.1016/j.jhep.2012.07.036
- 7Cochrane A, Evlampidou I, Irish C. Hepatitis B infection prevalence by country of birth in migrant populations in a large UK city. J Clin Virol. 2015; 68: 79–82. DOI: 10.1016/j.jcv.2015.05.009
- 8Perumalswami, Ponni V, Stephanie H. Hepatitis Outreach Network: A practical strategy for hepatitis screening with linkage to care in foreign-born communities. Journal of hepatology. 2013; 58(5): 890–897. DOI: 10.1016/j.jhep.2013.01.004
- 9Perumalswami, Ponni V, Stephanie H. Hepatitis Outreach Network: A practical strategy for hepatitis screening with linkage to care in foreign-born communities. Journal of Hepatology. 2013; 58(5): 890–897. DOI: 10.1016/j.jhep.2013.01.004
- 10Hahne SJ, Veldhuijzen IK. Infection with hepatitis B and C virus in Europe: A systematic review of prevalence and cost-effectiveness of screening. BMC Infect Dis. 2013; 13: 181. DOI: 10.1186/1471-2334-13-181
- 11Harris AM, Schoenbachler BT. Testing and linking foreign-born people with chronic hepatitis B virus infection to care at nine U.S. programs, 2012–2014. Public Health Rep. 2016; 131(2): 20–8. DOI: 10.1177/00333549161310S204
- 12Lee ACK, Vedio A. Determinants of uptake of hepatitis B testing and healthcare access by migrant Chinese in the England: A qualitative study. BMC Public Health. 2017; 17(1): 747. DOI: 10.1186/s12889-017-4796-4
- 13Govindasamy D1, Ford N. Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: A systematic review. AIDS. 2012; 26(16): 2059–67. DOI: 10.1097/QAD.0b013e3283578b9b
- 14Scalioni Lde P, Cruz HM, de Paula VS. Performance of rapid hepatitis C virus antibody assays among high- and low-risk populations. J Clin Virol. 2014; 60(3): 200–5. DOI: 10.1016/j.jcv.2014.04.001
- 15Bottero J, Boyd A, Gozlan J. Performance of rapid tests for detection of HBsAg and anti-HBsAb in a large cohort. France. J Hepatol. 2013; 58(3): 473–8. DOI: 10.1016/j.jhep.2012.11.016
- 16
Chinese Migration to Belgium – Trends and Perspectives . Myria, Belgian Federal Migration Centre. 2005. - 17Stanford J, Biba A. Community-engaged strategies to promote hepatitis B testing and linkage to care in immigrants of Florida. J Epidemiol Glob Health. 2016; 6(4): 277–284. DOI: 10.1016/j.jegh.2016.06.003
- 18Hyun CS, Kim S. Chronic hepatitis B in Korean Americans: Decreased prevalence and poor linkage to care. BMC Infect Dis. 2016; 16(1): 415. DOI: 10.1186/s12879-016-1732-7
- 19Sehr MA, Joshi KD. Markov modeling in hepatitis B screening and linkage to care. Theor Biol Med Model. 2017; 14(1): 11. DOI: 10.1186/s12976-017-0057-6
- 20Janjua NZ, Kuo M, Chong M. Assessing hepatitis C burden and treatment effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and characteristics of linked and unlinked participants. PLoS One. 2016; 11(3): e0150176. DOI: 10.1371/journal.pone.0150176
- 21Vanwolleghem T, Hou J, van Oord G. Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells. Hepatology. 2015; 62(1): 87–100. DOI: 10.1016/S0168-8278(15)30664-4 Epub 2015 Apr 27.
- 22European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017; 67(2): 370–398. DOI: 10.1016/j.jhep.2017.03.021
- 23Robotin MC, George J. Community-based hepatitis B screening: What works? Hepatol Int. 2014; 8(4): 478–92. DOI: 10.1007/s12072-014-9562-4
- 24European Association for the Study of the Liver, European Organisation for Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma. J Hepatol. 2012; 56(4): 908–43. DOI: 10.1016/j.jhep.2011.12.001
- 25The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology. 1994; 20(1 Pt 1): 15–20. DOI: 10.1002/hep.1840200104